Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Dapagliflozin (Forxiga) for type 2 diabetes?:
Clifford Bailey
School of Biosciences
College of Health and Life Sciences
Biosciences Research Group (BRG)
Cell & Tissue Biomedical Research
Aston Research Centre for Health in Ageing
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dapagliflozin (Forxiga) for type 2 diabetes?:'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
100%
Type 2 Diabetes Mellitus
48%
Glucose
40%
Cardiovascular Diseases
23%
Diet
22%
Renal Reabsorption
21%
Premature Mortality
18%
Metformin
17%
Blindness
16%
Patient Education
16%
Hypoglycemia
15%
Chronic Renal Insufficiency
14%
Weight Gain
14%
Weight Loss
13%
Life Style
13%
Diabetes Mellitus
12%
Insulin
10%
Therapeutics
10%
Pharmaceutical Preparations
6%